Gadolinium was created for use in Magnetic Resonance Imaging (MRI) in 1988. Soon after it became the preferred contrast agents in MRI’s administered to patients with kidney problems. This was because the agents in Gadolinium were thought to be safer than other iodine based contrast agents.
Gadolinium injections are used as an MRI (Magnetic Resonance Imaging) contrast agent because its magnetic properties allow healthcare professionals to better observe lesions with abnormal vascularity in the brain, spine, and associated tissues. When the doctor calls for a Gadolinium injection, a MRI is first taken without any injection followed by an MRI after the Gadolinium has been injected into the patient.
Gadolinium has several possible side effects, some less severe than others. The most concerning side effect of Gadolinium is nephrogenic systemic fibrosis. Nephrogenic Systemic Fibrosis (NSF) is a progressive disorder which is associated with the development of excessive scar tissue as well as thick, hardened and tight areas of skin which often cover the joints, resulting in severe limitations on movement.
There is no cure or effective treatment for NSF, and it has lead to death in some cases. The victim may become unable to walk or fully move the joints of their arms, hands, legs and/or feet. Victims will become dependent on wheelchairs within weeks.
The most likely pre-existing conditions to allow for possible side effects when injected with the contrast dye Gadolinium, is kidney problems. This is because Gadolinium is flushed out of your system by your kidneys soon after it’s injected. When Gadolinium remains in your system too long, it can cause injuries that can be severe.